Trial Profile
A prospective, cohort study investigating safety and efficacy of Raltegravir based antiretroviral therapy in solid organ transplant HIV infected patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2016
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary) ; Abacavir; Emtricitabine; Lamivudine; Tenofovir
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 01 Mar 2016 New trial record